What does Araceli Biosciences do?
Araceli Biosciences is a biotechnology company that accelerates drug discovery by leveraging high-content imaging and AI-driven analysis. Its flagship Endeavor system and Clairvoyance software provide scientists with actionable insights across diverse biological applications.
How much did they raise?
The company raised $11.2M in a Seed financing round, with Board Chairman Bill Cortelyou acting as the lead investor.
What are their plans for the money?
The funds will be used to further develop their imaging and analytical platforms, potentially revolutionizing drug discovery and enhancing the efficiency of the research process.
What have they achieved so far?
Araceli Biosciences has already made significant progress with the introduction of its Endeavor system and Clairvoyance software, which are pivotal in transforming traditional drug discovery methods.
